Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects

PLoS ONE

Volumn 5, Issue 6, 2010, Pages 1-12

  Normand Lauziére, François ^a   Frisch, Frédérique ^a   Labbé, Sébastien M ^a   Bherer, Patrick ^a   Gagnon, René ^a   Cunnane, Stephen C ^b   Carpentier, André C ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Research Center on Aging   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; GLYCEROL; INSULIN; PALMITIC ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PROGENY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; FAMILY; MIDDLE AGED; OXIDATION REDUCTION REACTION;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FAMILY; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; POSTPRANDIAL PERIOD;

EID: 85009413459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010956     Document Type: Article

References (46)

1. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, et al. (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study [see comments]. Lancet 340: 925-929
2. Axelsen M, Smith U, Eriksson JW, Taskinen MR, Jansson PA (1999) Postprandial hypertriglyceridemia and insulin resistance in normoglycemic first-degree relatives of patients with type 2 diabetes. Annals of Internal Medicine 131: 27-31
3. Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23: 201-229
4. Brassard P, Frisch F, Lavoie F, Cyr D, Bourbonnais A, et al. (2008) Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes. J Clin Endocrinol Metab 93: 837-844
5. Lavoie F, Frisch F, Brassard P, Normand-Lauziere F, Cyr D, et al. (2009) Relationship between Total and High Molecular Weight Adiponectin Levels and Plasma Nonesterified Fatty Acid Tolerance during Enhanced Intravascular Triacylglycerol Lipolysis in Men. J Clin Endocrinol Metab 94: 998-1004
6. Carpentier AC, Bourbonnais A, Frisch F, Giacca A, Lewis GF (2010) Plasma nonesterified Fatty Acid intolerance and hyperglycemia are associated with intravenous lipid-induced impairment of insulin sensitivity and disposition index. J Clin Endocrinol Metab 95: 1256-1264
7. Anonymous (2004) Diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl 1: S5-S10.
8. Carpentier A, Frisch F, Cyr D, Genereux P, Patterson BW, et al. (2005) On the suppression of plasma non-esterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am J Physiol Endocrinol Metab 289: E849-E856.
9. Park Y, Grellner WJ, Harris WS, Miles JM (2000) A new method for the study of chylomicron kinetics in vivo. Am J Physiol Endocrinol Metab 279: E1258-E1263.
10. Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe, RR (1998) Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. American Journal of Physiology 275: E798-E805.
11. Wolfe RR (1992) Measurement of substrate oxidation. In: Radioactive and stable isotope tracers in biomedicine. Principles and practice of kinetic analysis. New-York: Wiley-Liss. pp 235-282
12. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S (2003) What does the measurement of whole-body Fatty Acid rate of appearance in plasma by using a Fatty Acid tracer really mean? Diabetes 52: 1641-1648
13. Miles JM, Wooldridge D, Grellner WJ, Windsor S, Isley WL, et al. (2003) Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52: 675-681
14. Bickerton AS, Roberts R, Fielding BA, Hodson L, Blaak EE, et al. (2007) Preferential uptake of dietary Fatty acids in adipose tissue and muscle in the postprandial period. Diabetes 56: 168-176
15. Carpentier AC, Frisch F, Brassard P, Lavoie F, Bourbonnais A, et al. (2007) Mechanism of insulin-stimulated clearance of plasma nonesterified fatty acids in humans. Am J Physiol Endocrinol Metab 292: E693-E701.
16. Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 55: 628-634
17. Carpentier A, Patterson BW, Uffelman KD, Giacca A, Vranic M, et al. (2001) The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. Diabetes 50: 1402-1413
18. Beylot M, Martin C, Beaufrere B, Riou JP, Mornex R (1987) Determination of steady-state and nonsteady-state glycerol kinetics in humans unssing deuteriumlabeled tracer. J Lipid Res 28: 414-422
19. Blaak EE, Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA (2000) Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49: 2102-2107
20. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671
21. Befroy DE, Falk PK, Dufour S, Mason GF, de Graaf RA, et al. (2007) Impaired Mitochondrial Substrate Oxidation in Muscle of Insulin-Resistant Offspring of Type 2 Diabetic Patients. Diabetes 56: 1376-1381
22. Heilbronn LK, Gregersen S, Shirkhedkar D, Hu D, Campbell LV (2007) Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes 56: 2046-2053
23. Guo ZK, Hensrud DD, Johnson CM, Jensen MD (1999) Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 48: 1586-1592
24. Blaak EE, Hul G, Verdich C, Stich V, Martinez A, et al. (2006) Fat oxidation before and after a high fat load in the obese insulin-resistant state. J Clin Endocrinol Metab 91: 1462-1469
25. Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH (2001) Plasma free Fatty Acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50: 2548-2554
26. Blaak EE, Wagenmakers AJ, Glatz JF, Wolffenbuttel BH, Kemerink GJ, et al. (2000) Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279: E146-E154.
27. Blaak EE, Wagenmakers AJ (2002) The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects. Diabetes 51: 784-789
28. Hulver MW, Berggren JR, Cortright RN, Dudek RW, Thompson RP, et al. (2003) Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284: E741-E747.
29. Blaak EE, Schiffelers SL, Saris WH, Mensink M, Kooi ME (2004) Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects. Diabetologia 47: 1462-1468
30. Jocken JW, Goossens GH, van Hees AM, Frayn KN, van BM, et al. (2008) Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men. Diabetologia 51: 320-327
31. Bickerton AS, Roberts R, Fielding BA, Tornqvist H, Blaak EE, et al. (2008) Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 51: 1466-1474
32. Schiffelers SL, Saris WH, van Baak MA (2001) The effect of an increased free fatty acid concentration on thermogenesis and substrate oxidation in obese and lean men. Int J Obes Relat Metab Disord 25: 33-38
33. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56
34. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, et al. (2007) Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50: 790-796
35. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, et al. (2007) Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56: 2085-2092
36. Hancock CR, Han DH, Chen M, Terada S, Yasuda T, et al. (2008) High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc Natl Acad Sci U S A 105: 7815-7820
37. Nair KS, Bigelow ML, Asmann YW, Chow LS, Coenen-Schimke JM, et al. (2008) Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes 57: 1166-1175
38. Holloszy JO (2009) Skeletal muscle ''mitochondrial deficiency'' does not mediate insulin resistance. Am J Clin Nutr 89: 463S-466S.
39. Ravikumar B, Carey PE, Snaar JE, Deelchand DK, Cook DB, et al. (2005) Realtime assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 288: E789-E797.
40. Barrows BR, Timlin MT, Parks EJ (2005) Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens. Diabetes 54: 2668-2673
41. Heath RB, Karpe F, Milne RW, Burdge GC, Wootton SA, et al. (2007) Dietary fatty acids make a rapid and substantial contribution to VLDL-triacylglycerol in the fed state. Am J Physiol Endocrinol Metab 292: E732-E739.
42. Miles JM, Park YS, Walewicz D, Russell-Lopez C, Windsor S, et al. (2004) Systemic and forearm triglyceride metabolism: fate of lipoprotein lipasegenerated glycerol and free Fatty acids. Diabetes 53: 521-527
43. Roust LR, Jensen MD (1993) Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 42: 1567-1573
44. Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, et al. (2009) Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis. Hepatology 50: 1087-1093
45. Bergouignan A, Schoeller DA, Votruba S, Simon C, Blanc S (2008) The acetate recovery factor to correct tracer-derived dietary fat oxidation in humans. Am J Physiol Endocrinol Metab 294: E645-E653.
46. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113: 1582-1588.